Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 3/2012

01-03-2012 | Original Article

Parenchyma-preserving hepatic resection for colorectal liver metastases

Authors: Maximilian von Heesen, Jochen Schuld, Jens Sperling, Frank Grünhage, Frank Lammert, Sven Richter, Martin K. Schilling, Otto Kollmar

Published in: Langenbeck's Archives of Surgery | Issue 3/2012

Login to get access

Abstract

Background

Hepatic resection of colorectal liver metastases is the only curative treatment option. As clinical and experimental data indicate that the extent of liver resection correlates with growth of residual metastases, the present study analyzes the potential benefit of a parenchyma-preserving liver surgery approach.

Methods

Data from a prospectively maintained database of patients undergoing liver resection for colorectal metastases were reviewed. Evaluation of outcome was performed using the Kaplan–Meier method. Correlations were calculated between clinical–pathological variables.

Results

One hundred sixty-three patients underwent 198 liver resections for colorectal metastases: 26 major hepatectomies, 65 minor anatomical resections, 78 non-anatomical resections, as well as 29 combinations of minor anatomical and non-anatomical procedures. Overall 1-, 3-, and 5-year survival was 93%, 62%, and 40%, respectively. Patients with repeated liver resections had a 5-year survival of 27%. Interestingly, large dissection areas were associated with a significant reduction of the 5-year survival rate (33%). Five-year survival after major hepatectomy was not significantly reduced.

Conclusion

For colorectal liver metastases, minor resections offer a prolonged survival compared to major hepatectomies. As patients with stage IV colorectal disease are candidates for repeat resections, preservation of hepatic parenchyma is of increasing importance in the setting of multi-modal and repeated therapy approaches.
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics 2009. CA Cancer J Clin 59:225–249PubMedCrossRef Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics 2009. CA Cancer J Clin 59:225–249PubMedCrossRef
2.
go back to reference Bengtsson G, Carlsson G, Hafström L, Jönsson PE (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141:586–589PubMedCrossRef Bengtsson G, Carlsson G, Hafström L, Jönsson PE (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141:586–589PubMedCrossRef
3.
go back to reference Goslin R, Steele G Jr, Zamcheck N, Mayer R, MacIntyre J (1982) Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 25:749–754PubMedCrossRef Goslin R, Steele G Jr, Zamcheck N, Mayer R, MacIntyre J (1982) Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 25:749–754PubMedCrossRef
4.
go back to reference de Brauw LM, van de Velde CJ, Bouwhuis-Hoogerwerf ML, Zwaveling A (1987) Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J Surg Oncol 34:81–86PubMedCrossRef de Brauw LM, van de Velde CJ, Bouwhuis-Hoogerwerf ML, Zwaveling A (1987) Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J Surg Oncol 34:81–86PubMedCrossRef
5.
go back to reference Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318PubMedCrossRef Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318PubMedCrossRef
6.
go back to reference Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCrossRef Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCrossRef
7.
go back to reference Jonas S, Thelen A, Benckert C, Spinelli A, Sammain S, Neumann U et al (2007) Extended resections of liver metastases from colorectal cancer. World J Surg 31:511–521PubMedCrossRef Jonas S, Thelen A, Benckert C, Spinelli A, Sammain S, Neumann U et al (2007) Extended resections of liver metastases from colorectal cancer. World J Surg 31:511–521PubMedCrossRef
8.
go back to reference Tanaka K, Shimada H, Matsumoto C, Matsuo K, Takeda K, Nagano Y et al (2008) Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer. World J Surg 32:2057–2069PubMedCrossRef Tanaka K, Shimada H, Matsumoto C, Matsuo K, Takeda K, Nagano Y et al (2008) Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer. World J Surg 32:2057–2069PubMedCrossRef
9.
go back to reference Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y et al (2008) Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg 247:109–117PubMedCrossRef Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y et al (2008) Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg 247:109–117PubMedCrossRef
10.
go back to reference Karanjia ND, Lordan JT, Quiney N, Fawcett WJ, Worthington TR, Remington J (2009) A comparison of right and extended right hepatectomy with all other hepatic resections for colorectal liver metastases: a ten-year study. Eur J Surg Oncol 35:65–70PubMedCrossRef Karanjia ND, Lordan JT, Quiney N, Fawcett WJ, Worthington TR, Remington J (2009) A comparison of right and extended right hepatectomy with all other hepatic resections for colorectal liver metastases: a ten-year study. Eur J Surg Oncol 35:65–70PubMedCrossRef
11.
go back to reference Sarpel U, Bonavia AS, Grucela A, Roayaie S, Schwartz ME, Labow DM (2009) Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol 16:379–384PubMedCrossRef Sarpel U, Bonavia AS, Grucela A, Roayaie S, Schwartz ME, Labow DM (2009) Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol 16:379–384PubMedCrossRef
12.
go back to reference Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46PubMedCrossRef Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46PubMedCrossRef
13.
go back to reference Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236:397–406PubMedCrossRef Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236:397–406PubMedCrossRef
14.
go back to reference Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206PubMedCrossRef Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206PubMedCrossRef
15.
go back to reference Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK et al (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 240:698–708PubMed Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK et al (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 240:698–708PubMed
16.
go back to reference Rashidi B, An Z, Sun FX, Sasson A, Gamagammi R, Moossa AR et al (1999) Minimal liver resection strongly stimulates the growth of human colon cancer in the liver of nude mice. Clin Exp Metastasis 17:497–500PubMedCrossRef Rashidi B, An Z, Sun FX, Sasson A, Gamagammi R, Moossa AR et al (1999) Minimal liver resection strongly stimulates the growth of human colon cancer in the liver of nude mice. Clin Exp Metastasis 17:497–500PubMedCrossRef
17.
go back to reference Drixler TA, Borel Rinkes IH, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE (2000) Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res 60:1761–1765PubMed Drixler TA, Borel Rinkes IH, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE (2000) Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res 60:1761–1765PubMed
18.
go back to reference Delman KA, Zager JS, Bennett JJ, Malhotra S, Ebright MI, McAuliffe PF et al (2002) Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer. Ann Surg 236:337–342PubMedCrossRef Delman KA, Zager JS, Bennett JJ, Malhotra S, Ebright MI, McAuliffe PF et al (2002) Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer. Ann Surg 236:337–342PubMedCrossRef
19.
go back to reference Kollmar O, Menger MD, Schilling MK (2006) Macrophage inflammatory protein-2 contributes to liver resection-induced acceleration of hepatic metastatic tumor growth. World J Gastroenterol 12:858–867PubMed Kollmar O, Menger MD, Schilling MK (2006) Macrophage inflammatory protein-2 contributes to liver resection-induced acceleration of hepatic metastatic tumor growth. World J Gastroenterol 12:858–867PubMed
20.
go back to reference Kollmar O, Junker B, Rupertus K, Scheuer C, Menger MD, Schilling MK (2008) Liver resection-associated macrophage inflammatory protein-2 stimulates engraftment but not growth of colorectal metastasis at extrahepatic sites. J Surg Res 145:295–302PubMedCrossRef Kollmar O, Junker B, Rupertus K, Scheuer C, Menger MD, Schilling MK (2008) Liver resection-associated macrophage inflammatory protein-2 stimulates engraftment but not growth of colorectal metastasis at extrahepatic sites. J Surg Res 145:295–302PubMedCrossRef
21.
go back to reference Rupertus K, Kollmar O, Scheuer C, Junker B, Menger MD, Schilling MK (2007) Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells. Clin Exp Metastasis 24:39–48PubMedCrossRef Rupertus K, Kollmar O, Scheuer C, Junker B, Menger MD, Schilling MK (2007) Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells. Clin Exp Metastasis 24:39–48PubMedCrossRef
22.
go back to reference Stewart GD, O'Suilleabhain CB, Madhavan KK, Wigmore SJ, Parks RW, Garden OJ (2004) The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol 30:370–376PubMedCrossRef Stewart GD, O'Suilleabhain CB, Madhavan KK, Wigmore SJ, Parks RW, Garden OJ (2004) The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol 30:370–376PubMedCrossRef
23.
go back to reference Redaelli CA, Wagner M, Krähenbühl L, Gloor B, Schilling MK, Dufour JF et al (2002) Liver surgery in the era of tissue-preserving resections: early and late outcome in patients with primary and secondary hepatic tumors. World J Surg 26:1126–1132PubMedCrossRef Redaelli CA, Wagner M, Krähenbühl L, Gloor B, Schilling MK, Dufour JF et al (2002) Liver surgery in the era of tissue-preserving resections: early and late outcome in patients with primary and secondary hepatic tumors. World J Surg 26:1126–1132PubMedCrossRef
24.
go back to reference Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C (1996) Patient selection for hepatic resection of colorectal metastases. Arch Surg 131:322–329PubMedCrossRef Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C (1996) Patient selection for hepatic resection of colorectal metastases. Arch Surg 131:322–329PubMedCrossRef
25.
go back to reference Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H (2007) Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 121:395–400PubMedCrossRef Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H (2007) Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 121:395–400PubMedCrossRef
26.
go back to reference Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y et al (2002) Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 137:833–840PubMedCrossRef Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y et al (2002) Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 137:833–840PubMedCrossRef
27.
go back to reference Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982–999PubMedCrossRef Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982–999PubMedCrossRef
28.
go back to reference Bockhorn M, Frilling A, Frühauf NR, Neuhaus J, Molmenti E, Trarbach T et al (2008) Survival of patients with synchronous and metachronous colorectal liver metastases–is there a difference? J Gastrointest Surg 12:1399–1405PubMedCrossRef Bockhorn M, Frilling A, Frühauf NR, Neuhaus J, Molmenti E, Trarbach T et al (2008) Survival of patients with synchronous and metachronous colorectal liver metastases–is there a difference? J Gastrointest Surg 12:1399–1405PubMedCrossRef
29.
go back to reference Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197:233–241PubMedCrossRef Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197:233–241PubMedCrossRef
30.
go back to reference Bentrem DJ, Dematteo RP, Blumgart LH (2005) Surgical therapy for metastatic disease to the liver. Annu Rev Med 56:139–156PubMedCrossRef Bentrem DJ, Dematteo RP, Blumgart LH (2005) Surgical therapy for metastatic disease to the liver. Annu Rev Med 56:139–156PubMedCrossRef
31.
go back to reference Pulitanò C, Bodingbauer M, Aldrighetti L, Choti MA, Castillo F, Schulick RD, et al. (2011) Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection. Ann Surg Oncol (in press) Pulitanò C, Bodingbauer M, Aldrighetti L, Choti MA, Castillo F, Schulick RD, et al. (2011) Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection. Ann Surg Oncol (in press)
32.
go back to reference Oussoultzoglou E, Romain B, Panaro F, Rosso E, Pessaux P, Bachellier P et al (2009) Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens. Ann Surg 249:879–886PubMedCrossRef Oussoultzoglou E, Romain B, Panaro F, Rosso E, Pessaux P, Bachellier P et al (2009) Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens. Ann Surg 249:879–886PubMedCrossRef
33.
go back to reference Yamamoto J, Saiura A, Koga R, Seki M, Ueno M, Oya M et al (2005) Surgical treatment for metastatic malignancies. Nonanatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol 10:97–102PubMedCrossRef Yamamoto J, Saiura A, Koga R, Seki M, Ueno M, Oya M et al (2005) Surgical treatment for metastatic malignancies. Nonanatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol 10:97–102PubMedCrossRef
34.
go back to reference Yasui K, Shimizu Y (2005) Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol 10:86–96PubMedCrossRef Yasui K, Shimizu Y (2005) Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol 10:86–96PubMedCrossRef
35.
go back to reference DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y (2000) Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 4:178–184PubMedCrossRef DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y (2000) Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 4:178–184PubMedCrossRef
36.
go back to reference Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M et al (2001) Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 181:153–159PubMedCrossRef Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M et al (2001) Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 181:153–159PubMedCrossRef
37.
go back to reference Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, Muratore A et al (2006) Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10:86–94PubMedCrossRef Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, Muratore A et al (2006) Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10:86–94PubMedCrossRef
38.
go back to reference Finch RJ, Malik HZ, Hamady ZZ, Al-Mukhtar A, Adair R, Prasad KR et al (2007) Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br J Surg 94:1242–1248PubMedCrossRef Finch RJ, Malik HZ, Hamady ZZ, Al-Mukhtar A, Adair R, Prasad KR et al (2007) Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br J Surg 94:1242–1248PubMedCrossRef
39.
go back to reference Lalmahomed ZS, Ayez N, van der Pool AE, Verheij J, IJzermans JN, Verhoef C (2011) Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome? World J Surg 35:656–661PubMedCrossRef Lalmahomed ZS, Ayez N, van der Pool AE, Verheij J, IJzermans JN, Verhoef C (2011) Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome? World J Surg 35:656–661PubMedCrossRef
40.
go back to reference Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S et al (2002) Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235:863–871PubMedCrossRef Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S et al (2002) Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235:863–871PubMedCrossRef
41.
go back to reference Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H (2003) Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238:871–883PubMedCrossRef Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H (2003) Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238:871–883PubMedCrossRef
42.
go back to reference Thelen A, Jonas S, Benckert C, Schumacher G, Lopez-Hänninen E, Rudolph B et al (2007) Repeat liver resection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol 33:324–328PubMedCrossRef Thelen A, Jonas S, Benckert C, Schumacher G, Lopez-Hänninen E, Rudolph B et al (2007) Repeat liver resection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol 33:324–328PubMedCrossRef
43.
go back to reference Ahmad A, Chen SL, Bilchik AJ (2007) Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases. Arch Surg 142:526–531PubMedCrossRef Ahmad A, Chen SL, Bilchik AJ (2007) Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases. Arch Surg 142:526–531PubMedCrossRef
44.
go back to reference Pulitanò C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G et al (2010) What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB 12:244–249PubMed Pulitanò C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G et al (2010) What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB 12:244–249PubMed
45.
go back to reference Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722PubMedCrossRef Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722PubMedCrossRef
46.
go back to reference Thomas RL, Lordan JT, Devalia K, Quiney N, Fawcett W, Worthington TR et al (2011) Liver resection for colorectal cancer metastases involving the caudate lobe. Br J Surg 98:1476–1482PubMedCrossRef Thomas RL, Lordan JT, Devalia K, Quiney N, Fawcett W, Worthington TR et al (2011) Liver resection for colorectal cancer metastases involving the caudate lobe. Br J Surg 98:1476–1482PubMedCrossRef
47.
go back to reference de Haas RJ, Wicherts DA, Andreani P, Pascal G, Saliba F, Ichai P et al (2011) Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg 253:1069–1079PubMedCrossRef de Haas RJ, Wicherts DA, Andreani P, Pascal G, Saliba F, Ichai P et al (2011) Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg 253:1069–1079PubMedCrossRef
48.
go back to reference Abdalla EK, Ribero D, Pawlik TM, Zorzi D, Curley SA, Muratore A et al (2007) Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg 11:66–72PubMedCrossRef Abdalla EK, Ribero D, Pawlik TM, Zorzi D, Curley SA, Muratore A et al (2007) Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg 11:66–72PubMedCrossRef
49.
go back to reference Tanaka K, Nojiri K, Kumamoto T, Takeda K, Endo I (2011) R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy. Eur J Surg Oncol 37:336–343PubMedCrossRef Tanaka K, Nojiri K, Kumamoto T, Takeda K, Endo I (2011) R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy. Eur J Surg Oncol 37:336–343PubMedCrossRef
Metadata
Title
Parenchyma-preserving hepatic resection for colorectal liver metastases
Authors
Maximilian von Heesen
Jochen Schuld
Jens Sperling
Frank Grünhage
Frank Lammert
Sven Richter
Martin K. Schilling
Otto Kollmar
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Langenbeck's Archives of Surgery / Issue 3/2012
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-011-0872-x

Other articles of this Issue 3/2012

Langenbeck's Archives of Surgery 3/2012 Go to the issue